Akbal-Dagistan, O.; Sevim, M.; Sen, L.S.; Basarir, N.S.; Culha, M.; Erturk, A.; Fael, H.; Kaptan, E.; Sancar, S.; Mulazimoglu Durmusoglu, L.;
et al. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. Pharmaceutics 2022, 14, 2375.
https://doi.org/10.3390/pharmaceutics14112375
AMA Style
Akbal-Dagistan O, Sevim M, Sen LS, Basarir NS, Culha M, Erturk A, Fael H, Kaptan E, Sancar S, Mulazimoglu Durmusoglu L,
et al. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. Pharmaceutics. 2022; 14(11):2375.
https://doi.org/10.3390/pharmaceutics14112375
Chicago/Turabian Style
Akbal-Dagistan, Ozlem, Mustafa Sevim, Leyla Semiha Sen, Nur Sena Basarir, Meltem Culha, Aybige Erturk, Hanan Fael, Engin Kaptan, Serap Sancar, Lutfiye Mulazimoglu Durmusoglu,
and et al. 2022. "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects" Pharmaceutics 14, no. 11: 2375.
https://doi.org/10.3390/pharmaceutics14112375
APA Style
Akbal-Dagistan, O., Sevim, M., Sen, L. S., Basarir, N. S., Culha, M., Erturk, A., Fael, H., Kaptan, E., Sancar, S., Mulazimoglu Durmusoglu, L., Yegen, B. C., & Yildiz-Pekoz, A.
(2022). Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. Pharmaceutics, 14(11), 2375.
https://doi.org/10.3390/pharmaceutics14112375
